Literature DB >> 20561916

Isolation, characterization and cDNA sequencing of acrosin from turkey spermatozoa.

Mariola Słowińska1, Mariusz Olczak, Ewa Liszewska, Wiesław Watorek, Andrzej Ciereszko.   

Abstract

Acrosin (EC 3.4.21.10) is serine proteinase localized in the sperm acrosome and considered to play an essential role in fertilization. In contrast to mammalian, there are only limited data concerning avian acrosin, mostly focused on the characterization of mature enzyme. In the present study, acrosin was isolated from turkey spermatozoa using gel filtration in the presence of 4 M urea at acidic pH. N-terminal Edman sequencing allowed the identification of the first 26 N-terminal amino acids: VVGGTEALHG SWPWIVSIQNPRFAGT. This sequence was used to construct primers and obtain a cDNA sequence from the testis. The amino acid sequence deduced from the cDNA shows that turkey acrosin is initially synthesized as prepro-protein with 19-residue signal peptide. This signal sequence is followed by a 327-residue sequence corresponding to the acrosin zymogen. Turkey proacrosin does not contain a proline-rich segment at the C-terminal portion. Mature turkey acrosin is a two-chain molecule consisting of light and heavy chains and was found to be glycoprotein. The proacrosin/acrosin system exists in turkey spermatozoa and this system can be activated similarly to that of mammals. The high value of association constant strongly suggests that acrosin activity in turkeys can be controlled by a seminal plasma Kazal inhibitor under physiological conditions. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20561916     DOI: 10.1016/j.cbpb.2010.05.011

Source DB:  PubMed          Journal:  Comp Biochem Physiol B Biochem Mol Biol        ISSN: 1096-4959            Impact factor:   2.231


  1 in total

1.  The seminal acrosin-inhibitor ClTI1/SPINK2 is a fertility-associated marker in the chicken.

Authors:  Aurore Thélie; Sophie Rehault-Godbert; Jean-Claude Poirier; Marina Govoroun; Sophie Fouchécourt; Elisabeth Blesbois
Journal:  Mol Reprod Dev       Date:  2019-04-29       Impact factor: 2.609

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.